TY - JOUR
T1 - A qualitative exploration of patient perspectives on psychosocial burdens and positive factors in adults with osteogenesis imperfecta
AU - Members of the BBDC
AU - Rork, W. Conor
AU - Hertz, Alyssa G.
AU - Wiese, Andrew D.
AU - Kostick, Kristin M.
AU - Nguyen, Dianne
AU - Schneider, Sophie C.
AU - Shepherd, Whitney S.
AU - Cho, Hannah
AU - Lee, Brendan
AU - Sutton, V. Reid
AU - Nagamani, Sandesh C.S.
AU - Rauch, Frank
AU - Glorieux, Francis
AU - Retrouvey, Jean Marc
AU - Lee, Janice
AU - Esposito, Paul
AU - Wallace, Maegen
AU - Bober, Michael
AU - Eyre, David
AU - Gomez, Danielle
AU - Harris, Gerald
AU - Hart, Tracy
AU - Jain, Mahim
AU - Krakow, Deborah
AU - Krischer, Jeffrey
AU - Orwoll, Eric
AU - Nicol, Lindsey
AU - Raggio, Cathleen
AU - Smith, Peter
AU - Tosi, Laura
AU - Murali, Chaya N.
AU - Lee, Brendan
AU - Sutton, V. Reid
AU - Storch, Eric A.
N1 - Funding Information:
Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and National Institute of Mental Health under Award Number U54AR068069‐S1, and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under Award Number P50HD103555 for use of the Clinical and Translational Core facilities. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Funding Information:
The Brittle Bone Disease Consortium (1U54AR068069‐0) is a part of the National Center for Advancing Translational Sciences (NCATS) Rare Diseases Clinical Research Network (RDCRN), and is funded through a collaboration between the Office of Rare Diseases Research (ORDR), NCATS, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute of Dental and Craniofacial Research (NIDCR), the Eunice Kennedy Shriver National Institutes of Child Health and Development (NICHD), and the National Institute of Mental Health (NIMH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Funding Information:
W. Conor Rork, Alyssa G. Hertz, Andrew D. Wiese, and Kristin M. Kostick, Dianne Nguyen, Sophie C. Schneider, Whitney S. Shepherd, and Hannah Cho report no relevant disclosures. V. Reid Sutton discloses the following relationships: research funding from Ultragenyx; Osteogenesis Imperfecta Foundation Board of Directors member. Brendan Lee discloses the following relationships: research support from Safoni and Kyowa‐Kirin. Chaya N. Murali discloses the following relationships: research support from Biomarin Pharmaceuticals. Eric A. Storch discloses the following relationships: consultant for Biohaven Pharmaceuticals and Brainsway; Book royalties from Elsevier, Springer, American Psychological Association, Wiley, Oxford, Kingsley, and Guilford; Stock valued at less than $5000 from NView; Research support from NIH, International OCD Foundation, Ream Foundation, and Texas Higher Education Coordinating Board.
Publisher Copyright:
© 2023 Wiley Periodicals LLC.
PY - 2023
Y1 - 2023
N2 - Osteogenesis imperfecta (OI) is a pleiotropic, heritable connective tissue disorder associated with a wide range of health implications, including frequent bone fracture. While progress has been made to understand the spectrum of these physical health implications, the impact of OI on psychosocial well-being, as well as protective factors that buffer against adverse psychosocial outcomes, remain understudied. This present study relies on a qualitative approach to assess patient perspectives on both protective and adverse psychosocial factors specific to OI in 15 adults with varying disease status. Semi-structured interviews were conducted, subsequently coded, and themes extracted. Themes concerning psychosocial burdens (i.e., negative affective and behavioral impacts of disease status) and protective factors were identified from cooperatively-coded transcripts (two coders per transcript). Participants reported experiencing an increase in negative affect and disease-related distress after fracturing a bone and during recovery. Fear and concern specific to the uncertainty of future bone fractures and negative self-image was common. In contrast to these negative impacts, participants additionally described positive orientations toward their disease and attributed positive traits to their lived experience with a chronic disease. While limited due to small sample size and lack of ethno-racial diversity, findings highlight a need for continued research on the relationship between OI disease status and psychosocial outcomes, as well as the development of psychological interventions designed for OI populations. Findings have relevant clinical applications for healthcare providers working with those diagnosed with OI.
AB - Osteogenesis imperfecta (OI) is a pleiotropic, heritable connective tissue disorder associated with a wide range of health implications, including frequent bone fracture. While progress has been made to understand the spectrum of these physical health implications, the impact of OI on psychosocial well-being, as well as protective factors that buffer against adverse psychosocial outcomes, remain understudied. This present study relies on a qualitative approach to assess patient perspectives on both protective and adverse psychosocial factors specific to OI in 15 adults with varying disease status. Semi-structured interviews were conducted, subsequently coded, and themes extracted. Themes concerning psychosocial burdens (i.e., negative affective and behavioral impacts of disease status) and protective factors were identified from cooperatively-coded transcripts (two coders per transcript). Participants reported experiencing an increase in negative affect and disease-related distress after fracturing a bone and during recovery. Fear and concern specific to the uncertainty of future bone fractures and negative self-image was common. In contrast to these negative impacts, participants additionally described positive orientations toward their disease and attributed positive traits to their lived experience with a chronic disease. While limited due to small sample size and lack of ethno-racial diversity, findings highlight a need for continued research on the relationship between OI disease status and psychosocial outcomes, as well as the development of psychological interventions designed for OI populations. Findings have relevant clinical applications for healthcare providers working with those diagnosed with OI.
KW - anxiety
KW - brittle bone disease
KW - osteogenesis imperfecta
KW - pain
KW - patient perspectives
KW - treatment
UR - http://www.scopus.com/inward/record.url?scp=85161906730&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85161906730&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.63323
DO - 10.1002/ajmg.a.63323
M3 - Article
C2 - 37317786
AN - SCOPUS:85161906730
SN - 1552-4825
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
ER -